The neurostimulation devices market size has grown rapidly in recent years. It will grow from $6.86 billion in 2025 to $7.64 billion in 2026 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increasing prevalence of chronic neurological disorders, wider clinical acceptance of implantable stimulation therapies, expansion of pain management treatment protocols, growing neurological disease diagnosis rates, availability of advanced implant technologies.
The neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $12.03 billion in 2030 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to increasing demand for personalized neuromodulation therapies, rising adoption of minimally invasive neurostimulation devices, growing investments in brain-computer interface research, expansion of home-based neuromodulation treatments, increasing regulatory approvals for novel stimulation indications. Major trends in the forecast period include increasing adoption of closed-loop neurostimulation systems, rising use of personalized neuromodulation therapies, growing integration of wireless and miniaturized implants, expansion of external non-invasive stimulation devices, enhanced focus on long-term therapy adjustability.
The growing demand within the healthcare industry is expected to drive the expansion of the neurostimulation devices market in the future. The healthcare industry is a broad and complex sector that includes various organizations, professionals, and institutions focused on delivering medical services, healthcare products, and improving overall health. Neurostimulation devices play a crucial role in this sector, especially in treating and managing neurological conditions and chronic pain. For example, in May 2023, a report from the Office for National Statistics, a UK-based government agency, revealed that healthcare spending in the UK increased by 5.6% from 2022 to 2023, compared to a 0.9% growth in 2022. In 2023, UK healthcare expenditure was approximately $322.152 billion (£292 billion). As a result, the expanding healthcare industry is contributing to the growth of the neurostimulation devices market.
Major companies operating in the neurostimulation devices market are concentrating on closed-loop spinal cord stimulation (SCS) systems to provide adaptive therapy that more closely corresponds to patients’ everyday movements. Closed-loop SCS involves systems that detect physiological signals along the spinal cord and automatically modify stimulation in real time, rather than delivering fixed-output electrical pulses. For example, in April 2024, Medtronic plc, a US-based healthcare technology company, obtained FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator. The device includes real-time sensing of biological signals, automatically regulates stimulus intensity, supports multiple waveforms (including its proprietary DTM therapy), and enables full-body 3T MRI access.
In November 2024, Medtronic plc, an Ireland-based medical device company, acquired Fortimedix Surgical for an undisclosed sum. Through this acquisition, Medtronic seeks to enhance its surgical and endoscopy portfolio, particularly to support its upcoming Hugo soft-tissue robotic system. Fortimedix is a Netherlands-based company that provides neurostimulation devices.
Major companies operating in the neurostimulation devices market are Medtronic plc, Cyberonics Inc., Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc., MindMaze, NeuroMetrix, Nexeon MedSystems, Nuvectra, Saluda Medical, SPR Therapeutics Inc., Uro Medical Corporation.
North America was the largest region in the global neurostimulation devices market in 2025. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurostimulation devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the neurostimulation devices market by increasing costs of imported electronic components, implantable materials, microcontrollers, sensors, and precision manufacturing equipment used in spinal cord, deep brain, and vagus nerve stimulators. North America and Europe are particularly affected due to reliance on global semiconductor and medical-grade component supply chains, while Asia-Pacific faces cost pressures in export-oriented device manufacturing. These tariffs are increasing production costs and device pricing, which may slow adoption in cost-sensitive healthcare settings. However, tariffs are also encouraging local manufacturing, regional sourcing of electronic components, and investments in domestic medical device production capabilities, strengthening long-term supply chain resilience.
The neurostimulation devices market research report is one of a series of new reports that provides neurostimulation devices market statistics, including neurostimulation devices industry global market size, regional shares, competitors with a neurostimulation devices market share, detailed neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurostimulation devices industry. This neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurostimulation devices are medical instruments designed to deliver electrical impulses to specific areas of the nervous system to modulate nerve activity. These devices are typically implanted or placed on the body to treat a range of neurological conditions. Neurostimulation works by altering or blocking pain signals or by stimulating specific neural pathways to restore function. These devices aim to enhance patients' quality of life by providing targeted, adjustable therapy tailored to individual needs.
The primary products in the neurostimulation devices market can be categorized into implantable devices and external devices. Implantable devices include cochlear implants, deep brain stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and gastric electric stimulation devices. External devices encompass transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). These devices are used in a variety of applications, including pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, and Parkinson's disease. They are employed by different healthcare facilities, such as hospitals, rehabilitation centers, and medical clinics.
The neurostimulation devices market consists of sales of spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neurostimulation devices market size is expected to see rapid growth in the next few years. It will grow to $12.03 billion in 2030 at a compound annual growth rate (CAGR) of 12%. The growth in the forecast period can be attributed to increasing demand for personalized neuromodulation therapies, rising adoption of minimally invasive neurostimulation devices, growing investments in brain-computer interface research, expansion of home-based neuromodulation treatments, increasing regulatory approvals for novel stimulation indications. Major trends in the forecast period include increasing adoption of closed-loop neurostimulation systems, rising use of personalized neuromodulation therapies, growing integration of wireless and miniaturized implants, expansion of external non-invasive stimulation devices, enhanced focus on long-term therapy adjustability.
The growing demand within the healthcare industry is expected to drive the expansion of the neurostimulation devices market in the future. The healthcare industry is a broad and complex sector that includes various organizations, professionals, and institutions focused on delivering medical services, healthcare products, and improving overall health. Neurostimulation devices play a crucial role in this sector, especially in treating and managing neurological conditions and chronic pain. For example, in May 2023, a report from the Office for National Statistics, a UK-based government agency, revealed that healthcare spending in the UK increased by 5.6% from 2022 to 2023, compared to a 0.9% growth in 2022. In 2023, UK healthcare expenditure was approximately $322.152 billion (£292 billion). As a result, the expanding healthcare industry is contributing to the growth of the neurostimulation devices market.
Major companies operating in the neurostimulation devices market are concentrating on closed-loop spinal cord stimulation (SCS) systems to provide adaptive therapy that more closely corresponds to patients’ everyday movements. Closed-loop SCS involves systems that detect physiological signals along the spinal cord and automatically modify stimulation in real time, rather than delivering fixed-output electrical pulses. For example, in April 2024, Medtronic plc, a US-based healthcare technology company, obtained FDA approval for its Inceptiv closed-loop rechargeable spinal cord stimulator. The device includes real-time sensing of biological signals, automatically regulates stimulus intensity, supports multiple waveforms (including its proprietary DTM therapy), and enables full-body 3T MRI access.
In November 2024, Medtronic plc, an Ireland-based medical device company, acquired Fortimedix Surgical for an undisclosed sum. Through this acquisition, Medtronic seeks to enhance its surgical and endoscopy portfolio, particularly to support its upcoming Hugo soft-tissue robotic system. Fortimedix is a Netherlands-based company that provides neurostimulation devices.
Major companies operating in the neurostimulation devices market are Medtronic plc, Cyberonics Inc., Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, Neuronetics Inc., NeuroPace Inc., NeuroSigma Inc., NDI Medical LLC, Synapse Biomedical Inc., MED-EL, LivaNova PLC, Aleva Neurotherapeutics, BrainsWay, Cortec Corporation, Endonovo Therapeutics Inc., Inspire Medical Systems Inc., The Magstim Company Limited, Mainstay Medical Limited, MicroTransponder Inc., MindMaze, NeuroMetrix, Nexeon MedSystems, Nuvectra, Saluda Medical, SPR Therapeutics Inc., Uro Medical Corporation.
North America was the largest region in the global neurostimulation devices market in 2025. Asia-Pacific was the second-largest region in the neurostimulation devices market. The regions covered in the neurostimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neurostimulation devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Tariffs are impacting the neurostimulation devices market by increasing costs of imported electronic components, implantable materials, microcontrollers, sensors, and precision manufacturing equipment used in spinal cord, deep brain, and vagus nerve stimulators. North America and Europe are particularly affected due to reliance on global semiconductor and medical-grade component supply chains, while Asia-Pacific faces cost pressures in export-oriented device manufacturing. These tariffs are increasing production costs and device pricing, which may slow adoption in cost-sensitive healthcare settings. However, tariffs are also encouraging local manufacturing, regional sourcing of electronic components, and investments in domestic medical device production capabilities, strengthening long-term supply chain resilience.
The neurostimulation devices market research report is one of a series of new reports that provides neurostimulation devices market statistics, including neurostimulation devices industry global market size, regional shares, competitors with a neurostimulation devices market share, detailed neurostimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the neurostimulation devices industry. This neurostimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neurostimulation devices are medical instruments designed to deliver electrical impulses to specific areas of the nervous system to modulate nerve activity. These devices are typically implanted or placed on the body to treat a range of neurological conditions. Neurostimulation works by altering or blocking pain signals or by stimulating specific neural pathways to restore function. These devices aim to enhance patients' quality of life by providing targeted, adjustable therapy tailored to individual needs.
The primary products in the neurostimulation devices market can be categorized into implantable devices and external devices. Implantable devices include cochlear implants, deep brain stimulation devices, spinal cord stimulation devices, vagus nerve stimulation devices, sacral nerve stimulation devices, and gastric electric stimulation devices. External devices encompass transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). These devices are used in a variety of applications, including pain management, epilepsy, essential tremor, urinary and fecal incontinence, depression, dystonia, gastroparesis, and Parkinson's disease. They are employed by different healthcare facilities, such as hospitals, rehabilitation centers, and medical clinics.
The neurostimulation devices market consists of sales of spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neurostimulation Devices Market Characteristics
3. Neurostimulation Devices Market Supply Chain Analysis
4. Global Neurostimulation Devices Market Trends and Strategies
5. Neurostimulation Devices Market Analysis of End Use Industries
7. Global Neurostimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neurostimulation Devices Total Addressable Market (TAM) Analysis for the Market
9. Neurostimulation Devices Market Segmentation
10. Neurostimulation Devices Market Regional and Country Analysis
11. Asia-Pacific Neurostimulation Devices Market
12. China Neurostimulation Devices Market
13. India Neurostimulation Devices Market
14. Japan Neurostimulation Devices Market
15. Australia Neurostimulation Devices Market
16. Indonesia Neurostimulation Devices Market
17. South Korea Neurostimulation Devices Market
18. Bangladesh Neurostimulation Devices Market
19. Thailand Neurostimulation Devices Market
20. Vietnam Neurostimulation Devices Market
21. Malaysia Neurostimulation Devices Market
22. Singapore Neurostimulation Devices Market
23. Philippines Neurostimulation Devices Market
24. Hong Kong Neurostimulation Devices Market
25. New Zealand Neurostimulation Devices Market
26. Taiwan Neurostimulation Devices Market
27. South East Asia Neurostimulation Devices Market
28. Western Europe Neurostimulation Devices Market
29. UK Neurostimulation Devices Market
30. Germany Neurostimulation Devices Market
31. France Neurostimulation Devices Market
32. Italy Neurostimulation Devices Market
33. Spain Neurostimulation Devices Market
34. Austria Neurostimulation Devices Market
35. Belgium Neurostimulation Devices Market
36. Denmark Neurostimulation Devices Market
37. Finland Neurostimulation Devices Market
38. Ireland Neurostimulation Devices Market
39. Netherlands Neurostimulation Devices Market
40. Norway Neurostimulation Devices Market
41. Portugal Neurostimulation Devices Market
42. Sweden Neurostimulation Devices Market
42. Switzerland Neurostimulation Devices Market
43. Eastern Europe Neurostimulation Devices Market
44. Russia Neurostimulation Devices Market
45. Czech Republic Neurostimulation Devices Market
46. Poland Neurostimulation Devices Market
47. Romania Neurostimulation Devices Market
48. Ukraine Neurostimulation Devices Market
49. North America Neurostimulation Devices Market
50. USA Neurostimulation Devices Market
51. Canada Neurostimulation Devices Market
52. Mexico Neurostimulation Devices Market
53. South America Neurostimulation Devices Market
54. Brazil Neurostimulation Devices Market
55. Chile Neurostimulation Devices Market
56. Argentina Neurostimulation Devices Market
57. Colombia Neurostimulation Devices Market
58. Peru Neurostimulation Devices Market
59. Middle East Neurostimulation Devices Market
60. Saudi Arabia Neurostimulation Devices Market
61. Israel Neurostimulation Devices Market
62. Iran Neurostimulation Devices Market
63. Turkey Neurostimulation Devices Market
64. United Arab Emirates Neurostimulation Devices Market
65. Africa Neurostimulation Devices Market
66. Egypt Neurostimulation Devices Market
67. Nigeria Neurostimulation Devices Market
68. South Africa Neurostimulation Devices Market
70. Neurostimulation Devices Market Competitive Landscape and Company Profiles
71. Neurostimulation Devices Market Other Major and Innovative Companies
74. Neurostimulation Devices Market High Potential Countries, Segments and Strategies
75. Appendix
List of Tables
Executive Summary
Neurostimulation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neurostimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neurostimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neurostimulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Implantable Devices; External Devices2) By Application: Pain Management; Epilepsy; Essential Tremor; Urinary and Fecal Incontinence; Depression; Dystonia; Gastroparesis; Parkinson's Disease
3) By End User: Hospitals; Rehabilitation Centers; Medical Clinic
Subsegments:
1) By Implantable Devices: Spinal Cord Stimulators (SCS); Deep Brain Stimulators (DBS); Vagus Nerve Stimulators (VNS); Sacral Nerve Stimulators (SNS)2) By External Devices: Transcranial Magnetic Stimulation (TMS) Devices; Transcranial Direct Current Stimulation (tDCS) Devices; Cranial Electrotherapy Stimulation (CES) Devices
Companies Mentioned: Medtronic plc; Cyberonics Inc.; Boston Scientific Corporation; Abbott Laboratories; Nevro Corporation; Neuronetics Inc.; NeuroPace Inc.; NeuroSigma Inc.; NDI Medical LLC; Synapse Biomedical Inc.; MED-EL; LivaNova PLC; Aleva Neurotherapeutics; BrainsWay; Cortec Corporation; Endonovo Therapeutics Inc.; Inspire Medical Systems Inc.; The Magstim Company Limited; Mainstay Medical Limited; MicroTransponder Inc.; MindMaze; NeuroMetrix; Nexeon MedSystems; Nuvectra; Saluda Medical; SPR Therapeutics Inc.; Uro Medical Corporation
Countries: China; India; Japan; Australia; Indonesia; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; Taiwan; New Zealand; UK; Germany; France; Italy; Spain; Austria; Belgium; Denmark; Finland; Ireland; Netherlands; Norway; Portugal; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neurostimulation Devices market report include:- Medtronic plc
- Cyberonics Inc.
- Boston Scientific Corporation
- Abbott Laboratories
- Nevro Corporation
- Neuronetics Inc.
- NeuroPace Inc.
- NeuroSigma Inc.
- NDI Medical LLC
- Synapse Biomedical Inc.
- MED-EL
- LivaNova PLC
- Aleva Neurotherapeutics
- BrainsWay
- Cortec Corporation
- Endonovo Therapeutics Inc.
- Inspire Medical Systems Inc.
- The Magstim Company Limited
- Mainstay Medical Limited
- MicroTransponder Inc.
- MindMaze
- NeuroMetrix
- Nexeon MedSystems
- Nuvectra
- Saluda Medical
- SPR Therapeutics Inc.
- Uro Medical Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.64 Billion |
| Forecasted Market Value ( USD | $ 12.03 Billion |
| Compound Annual Growth Rate | 12.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
